Skip to main content
. Author manuscript; available in PMC: 2013 Mar 18.
Published in final edited form as: Head Neck. 2009 Oct;31(10):1263–1273. doi: 10.1002/hed.21103

Table 1.

Combination Index of the SCCHN Cells Treated with Docetaxel, Cisplatin, and ZD1839

DP DZ PZ DPZ DP→z Z→DP
Tu212 0.76 ± 0.20 0.41 ± 0.21 0.75 ± 0.08 0.37 ± 0.08 0.60 ± 0.27 0.80 ± 0.35
Tu177 0.84 ± 0.28 0.60 ± 0.16 0.85 ± 0.14 0.52 ± 0.11 0.50 ± 0.22 1.10. ± 0.15
SqCC/YI 1.16 ± 0.46 0.47 ± 0.07 0.87 ± 0.20 0.48 ± 0.16 0.50 ± 0.08 1.16 ± 0.46

Note: DP, docetaxel plus cisplatin; DZ, docetaxel plus ZD1839; PZ, cisplatin plus ZD1839; DPZ, docetaxel, cisplatin, and ZD1839 simultaneously; DP→Z, docetaxel and cisplatin followed by ZD1839; Z→DP.ZD1839 followed by docetaxel and cisplatin.